![]() |
Sign Up! | Tags | Domains | Statistics | Options | Advanced Search |
![Abbott Seeks Approval of First Pediatric Indication for Humira® [PharmaGazette]](http://imageserver.news.speeple.com/4/e/9/3/e/a/a/d/a/b/826299ae26f59fbfb51960.jpeg)
Tagged: eu, abbott, drug regulations and approval, emea, ra, as, humira
Abbott (NYSE: ABT) has simultaneously submitted regulatory applications for its drug product HUMIRA® (adalimumab): a supplemental Biologics License Application (sBLA) with the USFDA seeking approval to market HUMIRA® (adalimumab) as a treatment for juvenile rheumatoid arthritis (JRA) in the U.S. a Type II Variation to the European Medicines Agency (EMEA) seeking approval to market HUMIRA® … Continue Reading »